Scienture Holdings, Inc. current report, 09 September 2021

Business Context and Reporting Period

This Form 8-K is a current report filed by TRxADE Health, Inc. (noting a discrepancy with the request metadata which listed "Scienture Holdings, Inc.") on September 9, 2021. The registrant is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol MEDS. The filing serves as a Regulation FD disclosure regarding upcoming investor communications.

Key Financial Metrics

The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report is informational regarding corporate events rather than a financial statement.

Material Changes

No material changes to financial performance or operations are reported in this document. The filing announces the Company's participation in three virtual investor conferences and roadshows scheduled for September 2021:

  • Colliers 5th Annual Investor Conference: September 9, 2021 (Virtual, One-on-One Meetings).
  • H.C. Wainwright 23rd Annual Global Investment Conference: September 13, 2021 (Virtual, On-Demand Presentation).
  • Benzinga Healthcare Virtual Conference: September 29, 2021 (Virtual, Webcast).

Guidance, Outlook, and Risks

The filing references a presentation (Exhibit 99.1) and a press release (Exhibit 99.2) containing forward-looking statements. Management cautions that these statements involve risks and uncertainties that could cause actual results to differ materially. The filing explicitly states that the information provided is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth. The Company disclaims any obligation to update these forward-looking statements.

Investor Verification Checklist

  • Verify the correct registrant name is TRxADE Health, Inc. (Ticker: MEDS), as the request metadata incorrectly identified "Scienture Holdings, Inc."
  • Review Exhibit 99.1 (August 2021 PowerPoint Presentation) for specific financial guidance and strategic outlook not detailed in the 8-K text.
  • Confirm the Company's status as an Emerging Growth Company as indicated by the checkmark in the filing.
  • Note that the webcast links provided are for informational purposes only and are not incorporated into the report.